Clinical Trial Type: Prostate

Name of this trial: Ideate-Prostate-01 What type of cancer is this for? Prostate Cancer Who is this trial for? Patients with metastatic castration-resistant prostate cancer What biomarkers are involved? n/a What is the National Clinical Trial #? NCT06925737  Brief summary of this trial: A Phase 3, Open-label Study of Ifinatamab Deruxtecan Versus Docetaxel in Participants